ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Ansun Biopharma Enrolls First Patient in Proof of Concept Trial of DAS181 for the Treatment of COVID-19
April 15, 2020Ansun Biopharma, Inc., a clinical stage biopharmaceutical company, today announced the enrollment of the first patient in a proof-of-concept study to evaluate the safety and efficacy of DAS181, the Company's investigational recombinant sialidase for the t
Pharma Sources Insight January 2025
